Unlock instant, AI-driven research and patent intelligence for your innovation.

A manganese dioxide/glucose oxidase@hyaluronic acid composite anticancer material and its preparation and application

A technology of glucose oxidase and manganese dioxide, applied in the fields of nanotechnology and cancer treatment, can solve the problems of insufficient selectivity and low anti-cancer activity, and achieve good selectivity, low toxicity and side effects, good basic research value and application prospects Effect

Active Publication Date: 2022-07-26
CHANGSHA UNIVERSITY OF SCIENCE AND TECHNOLOGY
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In order to solve the technical deficiencies of low anticancer activity and insufficient selectivity in existing anticancer materials, the present invention provides a manganese dioxide / glucose oxidase@hyaluronic acid composite anticancer material, aiming to provide a solution New material with good stability, excellent selectivity and anticancer activity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A manganese dioxide/glucose oxidase@hyaluronic acid composite anticancer material and its preparation and application
  • A manganese dioxide/glucose oxidase@hyaluronic acid composite anticancer material and its preparation and application
  • A manganese dioxide/glucose oxidase@hyaluronic acid composite anticancer material and its preparation and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Synthesis and Characterization of TSEN Nanomedicine in Example 1

[0046] (1) Take four groups of 500 μL manganese dioxide nanosheet original solutions (concentration of 0.5 mg·mL) -1 ; The above preparation example is prepared; the following experimental cases, unless otherwise stated, are solutions of this concentration) respectively and 10 μL glucose oxidase solution (5 mg·mL -1 , the following experimental cases, unless otherwise stated, are all solutions of this concentration) mixed;

[0047] (2) The above mixture was added to 1.5, 2, 2.5, and 3 mL of hyaluronic acid solution (2 mg·mL), respectively. -1 ), marked as group 1, group 2, group 3, group 4;

[0048] (3) After magnetic stirring at room temperature overnight (the time is about 12h), a suspension is obtained respectively;

[0049] (4) Put the above suspension at 6000r·min -1 Centrifuge at high speed for 20 min and wash with ultrapure water 2 to 3 times;

[0050] (5) The hydrated particle size of the fo...

Embodiment 2

[0055] Solution stability study of TSEN nanomedicine in Example 2

[0056] (1) The mixed system of manganese dioxide nanosheets and glucose oxidase (the ratio is the same as that in step (1) of Example 1) and the TSEN nanosystem (obtained in step (6) of Example 1) were added to deionized water (DI water). ), physiological saline (Saline), phosphate buffered saline (PBS), and cell culture medium (10% FBS Medium) containing 10% fetal bovine serum;

[0057] (2) wherein, the mixed system of manganese dioxide nanosheet and glucose oxidase is set as Control group;

[0058] (3) at room temperature, let stand for 30 days respectively;

[0059] (4) Observe and record the changes of TSEN in each solution.

[0060] Analysis of the results: from figure 2 The solution stability test of TSEN shows that the mixed system of manganese dioxide and glucose oxidase is deposited on the first day of standing in each solution, while TSEN can still be stably dispersed in deionized water after sta...

Embodiment 3

[0061] Study on the performance of TSEN nano-drug synergistically producing OH in Example 3

[0062] Prepare 25mM NaHCO 3 / 5%CO 2 Buffer solution is ready for use.

[0063] (1) Experimental group A: TSEN nanosystem (prepared in step (6) of Example 1), 2 mg·mL -1 ) added to the presence or absence of 120~150U·mL -1 25mM NaHCO for Hyaluronidase 3 / 5%CO 2 Buffer solution (containing 10 mM GSH, 10 mM glucose);

[0064] (2) Experimental group B: Control probe system (composed of manganese dioxide nanosheets and hyaluronic acid), TSEN nanosystem (2 mg·mL) -1 ) were added to 25mM NaHCO 3 / 5%CO 2 Buffer solution (containing 120~150U·mL -1 Hyaluronidase, 10 mM GSH, 10 mM glucose);

[0065] (3) place the above-mentioned A, B two groups of experimental solution systems to shake at 37°C respectively;

[0066] (4) Centrifuge after 4h, take the supernatant respectively;

[0067] (5) Then add 10 μg·mL -1 Methylene blue (MB) and 50 μM H 2 O 2 were respectively added to the supe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention belongs to the technical field of anticancer drugs, and specifically discloses a manganese dioxide / glucose oxidase@hyaluronic acid composite anticancer material, which comprises a core and a shell covering the core; the core comprises manganese dioxide nanosheets and glucose oxidase modified on its surface; the shell is hyaluronic acid. The invention also provides the preparation and application of the anticancer material. Studies have found that the composite material of the present invention can effectively synergistically improve the selectivity of cancer cells and normal cells through innovative components and the synergy of the composite morphology of the components, can kill cancer cells efficiently and specifically, and can be used at low A large number of apoptosis of cancer cells can be induced under the dosage; not only that, the material of the present invention basically does not affect the metabolism of normal cells, and the toxic and side effects are small.

Description

technical field [0001] The invention belongs to the fields of nanotechnology and cancer treatment, and relates to a nanocomposite medicine based on manganese dioxide nanosheets, glucose oxidase and hyaluronic acid. Background technique [0002] According to statistics from the World Health Organization in 2015, there were 8.8 million cancer deaths worldwide, and cancer has become the second leading cause of death in the world. To this day, cancer remains a major public health challenge. Conventional molecular therapy and chemotherapy based on tight ligand-receptor interaction or nucleic acid modification have the limitations of poor stability, poor specificity, and serious toxic and side effects. challenges posed by complexities such as drug resistance, drug resistance and metastasis. Since the early 1950s, researchers in related fields have successively developed many efficient cancer treatment methods, such as chemodynamic therapy, photodynamic therapy, photothermal ther...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/51A61K33/32A61K38/44A61K31/728A61P35/00
CPCA61K9/5161A61K33/32A61K38/443A61K31/728A61P35/00A61K2300/00
Inventor 卿志和杨荣华柏爱玲
Owner CHANGSHA UNIVERSITY OF SCIENCE AND TECHNOLOGY